Vascular endothelial cell-specific NF-kappaB suppression attenuates hypertension-induced renal damage

Area of Science:

• Cardiovascular Biology
• Molecular Medicine
• Renal Pathophysiology

Background:

• Nuclear factor kappa B (NF-kappaB) is implicated in hypertension-related vascular and organ damage.
• Endothelial cells play a critical role in regulating vascular tone and inflammation during hypertension.

Purpose of the Study:

• To investigate the therapeutic potential of suppressing endothelial cell-specific NF-kappaB activation in mitigating hypertension-induced renal injury.
• To establish a causal link between endothelial NF-kappaB signaling and the development of target-organ damage in hypertension.

Main Methods:

• Generation of Tie-1-DeltaN transgenic mice with endothelial cell-specific overexpression of a NF-kappaB super-repressor (IkappaBalphaDeltaN).
• Confirmation of cell-specific gene expression and NF-kappaB inhibition in vitro.
• Induction of hypertension using a high-salt diet, L-NAME, and angiotensin II infusion in Tie-1-DeltaN and control mice.
• Assessment of renal injury, inflammation, and albuminuria; gene expression analysis via RT-PCR.

Main Results:

• Hypertension (40-mm Hg increase) was successfully induced in both Tie-1-DeltaN and control mice.
• Tie-1-DeltaN mice exhibited significantly milder renal injury, reduced inflammation, and less albuminuria compared to controls.
• Expression of NF-kappaB target genes, VCAM-1 and ICAM-1, was markedly reduced in Tie-1-DeltaN mice.

Conclusions:

• Endothelial cell-specific suppression of NF-kappaB activation provides a protective effect against hypertension-induced renal damage.
• Targeting endothelial NF-kappaB signaling interrupts a critical cascade contributing to organ damage, irrespective of blood pressure levels.
• These findings highlight endothelial NF-kappaB as a key mediator and potential therapeutic target in hypertensive organ damage.